By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Resverlogix Corporation 

4820 Richard Road SW
Suite 300
Calgary  Alberta  T3E 6L1  Canada
Phone: 403-254-9252 Fax: 403-256-8495


SEARCH JOBS








Company News
Resverlogix Corporation (RVX.TO) Receives Two Patents For RVX-208 In China 4/7/2015 6:21:48 AM
EXCLUSIVE: Resverlogix Corporation (RVX.TO) CEO Says Experimental Cardiac Drug Holds High Hopes, As Biotech Booms 3/19/2015 12:26:47 PM
Resverlogix Corporation (RVX.TO) Presents At The Prestigious American College of Cardiology 64th Annual Scientific Session & Expo (ACC.15) 3/16/2015 1:56:22 PM
Resverlogix Corporation (RVX.TO) Collaborates With Emerald Logic To Identify Factors Driving Drug Response And Efficacy In Phase 2 Program 3/4/2015 7:40:15 AM
Resverlogix Corporation (RVX.TO) Presents At Biotech Showcase During J.P. Morgan Week 1/15/2015 10:06:46 AM
Resverlogix Corporation (RVX.TO) Names Michael Sweeney, M.D., As Senior Vice President Of Clinical Development 11/4/2014 8:20:05 AM
Resverlogix Corporation (RVX.TO) Announces Annual General Meeting Voting Results 10/9/2014 9:23:51 AM
Resverlogix Corporation (RVX.TO) Corporate Update Conference Call & Webcast Announcement 10/2/2014 7:54:11 AM
Resverlogix Corporation (RVX.TO)'s RVX-208 Leads To A 77 Percent Relative Risk Reduction Of Major Heart Events 9/2/2014 6:51:51 AM
Resverlogix Corporation (RVX.TO) Closes Additional $30 Million From Citibank Loan 8/18/2014 8:09:14 AM
12345678910...
//-->